A report based on millions of urine drug tests found the United States is facing a rise in the use of multiple drugs at once, which not only is often more deadly but complicates treatment efforts.
Category: CDC
Watch: The Feds May Reexamine Covid Protocols. Here’s Why You Should Care.
KFF Health News’ Céline Gounder explains the “five-day rule” on covid safety, how guidelines and testing have evolved, and how best to protect yourself and others.
Congressman Off-Base in Ad Claiming Fauci Shipped Covid to Montana Before the Pandemic
Facts don’t support claims by a likely Republican Senate candidate that a federal research laboratory in Montana infected bats with a coronavirus from China before the covid-19 outbreak.
Surge in Syphilis Cases Leads Some Providers to Ration Penicillin
Injectable penicillin is the go-to treatment for syphilis and the only treatment considered safe for pregnant people with the disease. But as rates of syphilis increase across the U.S., a shortage of the injectable has prompted some public health agencies to ration it.
How Fringe Anti-Science Views Infiltrated Mainstream Politics — And What It Means in 2024
Opposition to vaccines and other public health measures backed by science has become politically charged. That makes dangerous misinformation much harder to fight.
Rift Over When to Use N95s Puts Health Workers at Risk Again
The Centers for Disease Control and Prevention is considering fuzzy guidelines on infection control in hospitals, critics say, leaving employers free to cut corners on N95 masks and other protective measures.
GOP Presidential Hopefuls Use Trump’s Covid Record to Court Vaccine Skeptics
Candidates see former President Donald Trump’s embrace of his administration’s covid-19 vaccine policies as an opportunity to gain ground. So far, their efforts haven’t found traction.
Do Republican Spending Cuts Threaten Federal HIV Funding? For Some Programs, Yes.
Spending cuts proposed by a Republican-led House subcommittee would cut millions from HIV-related spending.
A New RSV Shot Could Help Protect Babies This Winter — If They Can Get It in Time
Supply problems, a high price tag, and bureaucratic obstacles are slowing the distribution of a therapy that can protect infants from the respiratory syncytial virus. That will leave them unnecessarily at risk of hospitalization this winter, pediatricians fear.
A New Era of Vaccines Leaves Old Questions About Prices Unanswered
The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?
